Blade Air Mobility, Inc. Reaffirms Financial Guidance for the Full Year 2024 and 2025
May 07, 2024 at 04:30 pm IST
Share
Blade Air Mobility, Inc. reaffirmed financial guidance for the full year 2024 and 2025. For the period, the company expects revenue of $240 million to $250 million.
For the year 2025, the company expects double-digit year-over-year revenue growth.
Blade Air Mobility, Inc. provides air transportation and logistics for hospitals across the United States. The Company transports human organs for transplant, and for passengers, with helicopter and fixed wing services primarily in the Northeast United States, Southern Europe and Western Canada. The Company's segments include Passenger and Medical. Its Passenger segment includes Short Distance and Jet and Other. Short Distance business consists primarily of helicopter and amphibious seaplane flights in the United States, Canada and Europe. Jet and Other business consist principally of non-medical jet charter and by-the-seat jet flights between New York and South Florida. Its Medical segment includes MediMobility Organ Transport, which consists primarily of transportation of human organs for transplant and/or the medical teams supporting these services. It also offers additional services including donor logistics coordination and support for evaluating potential donor organs.
BLADE AIR MOBILITY, INC. 
